|
DiPaola and his colleagues at
Rutgers a couple of years ago showed that at least part of the activity of PC SPES is
because in the herbs are botanical equivalents of animal estrogens, and at least some of
this is due to estrogenic activity, as evidenced by the fact that most of the men on this
have a decrease in libido, have breast tenderness, enlargement and other estrogenic type
responses. Adrian Dobs and her colleagues at Johns Hopkins University through peer
review was funded to do the first placebo control trial of this herbal remedy. This is in
100 men with hormone refractory disease, comparing it to a standard estrogenic treatment,
estradiol. She’s doing this in Baltimore and in Singapore, and measuring the kinds of
things one would need to show that a prostate cancer drug is effective. |